The global Recombinant DNA (rDNA) Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Recombinant DNA (rDNA) Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Recombinant DNA (rDNA) Technology in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Recombinant DNA (rDNA) Technology include F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company and Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant DNA (rDNA) Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA (rDNA) Technology.

Report Scope

The Recombinant DNA (rDNA) Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant DNA (rDNA) Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant DNA (rDNA) Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant DNA (rDNA) Technology Market Report

Report Metric	Details
Report Name	Recombinant DNA (rDNA) Technology Market
Segment by Type	Expression System Cloning Vector
Segment by Application	Biotechnology and Pharmaceutical Companies Academic and Government Research Institutes Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, GlaxoSmithKline plc, New England Biolabs., Cibus, Monsanto Company, Horizon Discovery Group PLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant DNA (rDNA) Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant DNA (rDNA) Technology Market report?

Ans: The main players in the Recombinant DNA (rDNA) Technology Market are F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer Inc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, GlaxoSmithKline plc, New England Biolabs., Cibus, Monsanto Company, Horizon Discovery Group PLC

What are the Application segmentation covered in the Recombinant DNA (rDNA) Technology Market report?

Ans: The Applications covered in the Recombinant DNA (rDNA) Technology Market report are Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Other

What are the Type segmentation covered in the Recombinant DNA (rDNA) Technology Market report?

Ans: The Types covered in the Recombinant DNA (rDNA) Technology Market report are Expression System, Cloning Vector

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Expression System

1.2.3 Cloning Vector

1.3 Market by Application

1.3.1 Global Recombinant DNA (rDNA) Technology Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Biotechnology and Pharmaceutical Companies

1.3.3 Academic and Government Research Institutes

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2019-2030)

2.2 Recombinant DNA (rDNA) Technology Growth Trends by Region

2.2.1 Global Recombinant DNA (rDNA) Technology Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Recombinant DNA (rDNA) Technology Historic Market Size by Region (2019-2024)

2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2025-2030)

2.3 Recombinant DNA (rDNA) Technology Market Dynamics

2.3.1 Recombinant DNA (rDNA) Technology Industry Trends

2.3.2 Recombinant DNA (rDNA) Technology Market Drivers

2.3.3 Recombinant DNA (rDNA) Technology Market Challenges

2.3.4 Recombinant DNA (rDNA) Technology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue

3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2019-2024)

3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2019-2024)

3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue

3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio

3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2023

3.5 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served

3.6 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service

3.7 Date of Enter into Recombinant DNA (rDNA) Technology Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant DNA (rDNA) Technology Breakdown Data by Type

4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2019-2024)

4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2025-2030)

5 Recombinant DNA (rDNA) Technology Breakdown Data by Application

5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2019-2024)

5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Recombinant DNA (rDNA) Technology Market Size (2019-2030)

6.2 North America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024)

6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2019-2030)

7.2 Europe Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024)

7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2019-2030)

8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2019-2024)

8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2019-2030)

9.2 Latin America Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024)

9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2019-2030)

10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024)

10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)

11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Detail

11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview

11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction

11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development

11.2 Profacgen

11.2.1 Profacgen Company Detail

11.2.2 Profacgen Business Overview

11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction

11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.2.5 Profacgen Recent Development

11.3 Amgen Inc

11.3.1 Amgen Inc Company Detail

11.3.2 Amgen Inc Business Overview

11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction

11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.3.5 Amgen Inc Recent Development

11.4 Novartis AG

11.4.1 Novartis AG Company Detail

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction

11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.4.5 Novartis AG Recent Development

11.5 GenScript

11.5.1 GenScript Company Detail

11.5.2 GenScript Business Overview

11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction

11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.5.5 GenScript Recent Development

11.6 Pfizer Inc

11.6.1 Pfizer Inc Company Detail

11.6.2 Pfizer Inc Business Overview

11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction

11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.6.5 Pfizer Inc Recent Development

11.7 Novo Nordisk A/S

11.7.1 Novo Nordisk A/S Company Detail

11.7.2 Novo Nordisk A/S Business Overview

11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction

11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.7.5 Novo Nordisk A/S Recent Development

11.8 Eli Lilly and Company

11.8.1 Eli Lilly and Company Company Detail

11.8.2 Eli Lilly and Company Business Overview

11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction

11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.8.5 Eli Lilly and Company Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction

11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.9.5 Sanofi Recent Development

11.10 Biocon

11.10.1 Biocon Company Detail

11.10.2 Biocon Business Overview

11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction

11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.10.5 Biocon Recent Development

11.11 GlaxoSmithKline plc

11.11.1 GlaxoSmithKline plc Company Detail

11.11.2 GlaxoSmithKline plc Business Overview

11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction

11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.11.5 GlaxoSmithKline plc Recent Development

11.12 New England Biolabs.

11.12.1 New England Biolabs. Company Detail

11.12.2 New England Biolabs. Business Overview

11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction

11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.12.5 New England Biolabs. Recent Development

11.13 Cibus

11.13.1 Cibus Company Detail

11.13.2 Cibus Business Overview

11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction

11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.13.5 Cibus Recent Development

11.14 Monsanto Company

11.14.1 Monsanto Company Company Detail

11.14.2 Monsanto Company Business Overview

11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction

11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.14.5 Monsanto Company Recent Development

11.15 Horizon Discovery Group PLC

11.15.1 Horizon Discovery Group PLC Company Detail

11.15.2 Horizon Discovery Group PLC Business Overview

11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction

11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024)

11.15.5 Horizon Discovery Group PLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

F. Hoffmann-La Roche Ltd (Genentech, Inc)

Eli Lilly and Company

Horizon Discovery Group plc

List of Tables

Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Expression System

Table 3. Key Players of Cloning Vector

Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Region (2019-2024)

Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Region (2025-2030)

Table 10. Recombinant DNA (rDNA) Technology Market Trends

Table 11. Recombinant DNA (rDNA) Technology Market Drivers

Table 12. Recombinant DNA (rDNA) Technology Market Challenges

Table 13. Recombinant DNA (rDNA) Technology Market Restraints

Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2019-2024)

Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2023)

Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Recombinant DNA (rDNA) Technology Product Solution and Service

Table 21. Date of Enter into Recombinant DNA (rDNA) Technology Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2019-2024)

Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2025-2030)

Table 27. Global Recombinant DNA (rDNA) Technology Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2019-2024)

Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2025-2030)

Table 31. North America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2025-2030) & (US$ Million)

Table 46. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Detail

Table 47. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview

Table 48. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product

Table 49. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 50. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development

Table 51. Profacgen Company Detail

Table 52. Profacgen Business Overview

Table 53. Profacgen Recombinant DNA (rDNA) Technology Product

Table 54. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 55. Profacgen Recent Development

Table 56. Amgen Inc Company Detail

Table 57. Amgen Inc Business Overview

Table 58. Amgen Inc Recombinant DNA (rDNA) Technology Product

Table 59. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 60. Amgen Inc Recent Development

Table 61. Novartis AG Company Detail

Table 62. Novartis AG Business Overview

Table 63. Novartis AG Recombinant DNA (rDNA) Technology Product

Table 64. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 65. Novartis AG Recent Development

Table 66. GenScript Company Detail

Table 67. GenScript Business Overview

Table 68. GenScript Recombinant DNA (rDNA) Technology Product

Table 69. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 70. GenScript Recent Development

Table 71. Pfizer Inc Company Detail

Table 72. Pfizer Inc Business Overview

Table 73. Pfizer Inc Recombinant DNA (rDNA) Technology Product

Table 74. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 75. Pfizer Inc Recent Development

Table 76. Novo Nordisk A/S Company Detail

Table 77. Novo Nordisk A/S Business Overview

Table 78. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product

Table 79. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 80. Novo Nordisk A/S Recent Development

Table 81. Eli Lilly and Company Company Detail

Table 82. Eli Lilly and Company Business Overview

Table 83. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product

Table 84. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 85. Eli Lilly and Company Recent Development

Table 86. Sanofi Company Detail

Table 87. Sanofi Business Overview

Table 88. Sanofi Recombinant DNA (rDNA) Technology Product

Table 89. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 90. Sanofi Recent Development

Table 91. Biocon Company Detail

Table 92. Biocon Business Overview

Table 93. Biocon Recombinant DNA (rDNA) Technology Product

Table 94. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 95. Biocon Recent Development

Table 96. GlaxoSmithKline plc Company Detail

Table 97. GlaxoSmithKline plc Business Overview

Table 98. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product

Table 99. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 100. GlaxoSmithKline plc Recent Development

Table 101. New England Biolabs. Company Detail

Table 102. New England Biolabs. Business Overview

Table 103. New England Biolabs. Recombinant DNA (rDNA) Technology Product

Table 104. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 105. New England Biolabs. Recent Development

Table 106. Cibus Company Detail

Table 107. Cibus Business Overview

Table 108. Cibus Recombinant DNA (rDNA) Technology Product

Table 109. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 110. Cibus Recent Development

Table 111. Monsanto Company Company Detail

Table 112. Monsanto Company Business Overview

Table 113. Monsanto Company Recombinant DNA (rDNA) Technology Product

Table 114. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 115. Monsanto Company Recent Development

Table 116. Horizon Discovery Group PLC Company Detail

Table 117. Horizon Discovery Group PLC Business Overview

Table 118. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product

Table 119. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2019-2024) & (US$ Million)

Table 120. Horizon Discovery Group PLC Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2023 VS 2030

Figure 3. Expression System Features

Figure 4. Cloning Vector Features

Figure 5. Global Recombinant DNA (rDNA) Technology Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2023 VS 2030

Figure 7. Biotechnology and Pharmaceutical Companies Case Studies

Figure 8. Academic and Government Research Institutes Case Studies

Figure 9. Other Case Studies

Figure 10. Recombinant DNA (rDNA) Technology Report Years Considered

Figure 11. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Recombinant DNA (rDNA) Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Recombinant DNA (rDNA) Technology Market Share by Region: 2023 VS 2030

Figure 14. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2023

Figure 15. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2023

Figure 17. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Recombinant DNA (rDNA) Technology Market Share by Country (2019-2030)

Figure 19. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2019-2030)

Figure 23. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2019-2030)

Figure 31. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2019-2030)

Figure 39. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2019-2030)

Figure 43. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 46. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 47. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 48. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 49. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 50. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 51. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 52. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 53. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 54. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 55. GlaxoSmithKline plc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 56. New England Biolabs. Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 57. Cibus Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 58. Monsanto Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 59. Horizon Discovery Group PLC Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions